Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandial muscle protein synthesis in rats by Wilson, Gabriel J. et al.
Leucine or carbohydrate supplementation reduces AMPK and eEF2
phosphorylation and extends postprandial muscle protein synthesis in rats
Gabriel J. Wilson,1 Donald K. Layman,1 Christopher J. Moulton,1 Layne E. Norton,1 Tracy G. Anthony,2
Christopher G. Proud,3 S. Indu Rupassara,4 and Peter J. Garlick4
1Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois; 2Department of Biochemistry
and Molecular Biology, Indiana University School of Medicine-Evansville, Evansville, Indiana; 3School of Biological
Sciences, University of Southampton, Southampton, United Kingdom; and 4Department of Animal Sciences, University
of Illinois, Urbana, Illinois
Submitted 16 May 2011; accepted in final form 6 September 2011
Wilson GJ, Layman DK, Moulton CJ, Norton LE, Anthony
TG, Proud CG, Rupassara SI, Garlick PJ. Leucine or carbohydrate
supplementation reduces AMPK and eEF2 phosphorylation and ex-
tends postprandial muscle protein synthesis in rats. Am J Physiol
Endocrinol Metab 301: E1236–E1242, 2011. First published Septem-
ber 13, 2011; doi:10.1152/ajpendo.00242.2011.—Muscle protein syn-
thesis (MPS) increases after consumption of a protein-containing meal
but returns to baseline values within 3 h despite continued elevations
of plasma amino acids and mammalian target of rapamycin
(mTORC1) signaling. This study evaluated the potential for supple-
mental leucine (Leu), carbohydrates (CHO), or both to prolong
elevated MPS after a meal. Male Sprague-Dawley rats (270 g)
trained to consume three meals daily were food deprived for 12 h, and
then blood and gastrocnemius muscle were collected 0, 90, or 180 min
after a standard 4-g test meal (20% whey protein). At 135 min
postmeal, rats were orally administered 2.63 g of CHO, 270 mg of
Leu, both, or water (sham control). Following test meal consumption,
MPS peaked at 90 min and then returned to basal (time 0) rates at 180
min, although ribosomal protein S6 kinase and eIF4E-binding pro-
tein-1 phosphorylation remained elevated. In contrast, rats adminis-
tered Leu and/or CHO supplements at 135 min postmeal maintained
peak MPS through 180 min. MPS was inversely associated with the
phosphorylation states of translation elongation factor 2, the “cellular
energy sensor” adenosine monophosphate-activated protein kinase-
(AMPK) and its substrate acetyl-CoA carboxylase, and increases in
the ratio of AMP/ATP. We conclude that the incongruity between
MPS and mTORC1 at 180 min reflects a block in translation elonga-
tion due to reduced cellular energy. Administering Leu or CHO
supplements 2 h after a meal maintains cellular energy status and
extends the postprandial duration of MPS.
eukaryotic elongation factor 2; adenosine 5=-monophosphate-acti-
vated protein kinase; translation initiation; translation elongation;
branched-chain amino acids; whey protein; mammalian target of
rapamycin complex 1
MUSCLE PROTEIN SYNTHESIS (MPS) is rapidly stimulated after
consumption of a protein-containing meal and is associated
with activation of translation initiation by hormone and nutri-
ent signals (29). Key regulatory points of translation initiation
include assembly of the eukaryotic initiation factor-4F (eIF4F)
complex and phosphorylation of the 70-kDa ribosomal protein
S6 kinase (S6K1). Stimulation of these initiation factors is
potentiated by insulin and the essential amino acid (EAA)
leucine (4, 5). After a meal, plasma concentrations of leucine
and insulin trigger the activation of eIF4F and S6K1. Assembly
of the eIF4F initiation complex involves phosphorylation of the
inhibitory eIF4E-binding protein-1 (4E-BP1), which releases
the initiation factor eIF4E and allows it to bind with eIF4G.
Binding of eIF4E with eIF4G promotes preparation of the
mRNA for binding to the 43S preinitiation complex. The
postprandial rise in insulin activates the PI3K-Akt-mTORC1
(phosphoinositide 3-kinase-protein kinase B-mammalian target
of rapamycin complex 1) signaling cascade (4), whereas leu-
cine acts downstream of Akt to stimulate mTORC1 through an
as-yet unidentified mechanism (12). Apart from the postpran-
dial rise in plasma leucine, MPS does not appear to be limited
by amino acids beyond those required to maintain basal levels
(31) or by eIF2-mediated formation of the 43S preinitiation
complex (6, 24).
Whereas the initial translation initiation response shortly
after a meal (2 h) has been well characterized, much less is
known about what determines the duration of peak MPS
following food intake. Two recent studies (8, 28) using pre-
cisely timed meals containing intact proteins confirmed that the
early postprandial rise of MPS (2 h) corresponded to in-
creases in plasma insulin and leucine, as well as assembly of
eIF4F and phosphorylation of S6K1 and 4E-BP1, but found
that MPS declined by 3 h despite continued elevations of
plasma leucine, mTORC1 signaling, and translation initiation.
This discordance between rates of MPS and initiation factor
activity suggests that events other than eIF4F complex assem-
bly and S6K1 phosphorylation determine the postprandial MPS
response. In both experiments, the postprandial rise and fall of
plasma insulin paralleled changes in MPS activity, suggesting
that a decline in plasma insulin may limit MPS activity 3 h
after a meal.
Consistent with the meal-feeding experiments, Bohé et al.
(9) infused a complete amino acid mixture into adult volunteers
for 6 h. The continuous infusion increased plasma amino acids
1.7-fold above basal levels and stimulated MPS for 2 h, but
MPS subsequently returned to baseline despite the continuous
infusion of amino acids. Contrary to these findings, Wilson
et al. (36) infused a large dose of leucine to neonatal pigs for
24 h, along with replacement amino acids to maintain basal
levels, and found that MPS remained elevated for the entire
infusion period. This discrepancy highlights the need for ad-
ditional research to elucidate factors that determine the dura-
tion of the postprandial anabolic period.
Potential explanations for the discordance between initiation
signals and the duration of MPS after a meal include 1) factors
or steps within mRNA translation becoming refractory (unre-
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sponsive) to external stimuli, 2) reduced availability of amino
acids, or 3) reduced signaling from insulin or other important
stimuli. The purpose of this study was to determine whether the
postprandial period of muscle anabolism can be extended by
supplemental doses of leucine, carbohydrates, or both or
whether MPS becomes refractory to anabolic stimuli and
requires a period of time to reset before it can be stimulated
again. A better understanding of the relationship between MPS
and the mechanisms leading to active mRNA translation in
muscle may have implications for maintenance of lean tissue
during weight loss or aging and for treatment of patients
suffering trauma or prolonged bed rest as well as for acceler-
ation of muscle development in athletes.
MATERIALS AND METHODS
Animals. Thirty-four Male Sprague-Dawley rats (269  7 g;
Harlan-Teklad, Madison, WI) were housed individually and main-
tained at 24°C with a 12-h reverse light cycle (light period: 1900–
0700). Rats were fed during the dark period and had free access to
water. The animal protocol and facilities were reviewed and approved
by the Institutional Animal Care and Use Committee of the University
of Illinois at Urbana-Champaign.
Meal-training protocol. Baseline diets provided 20, 50, and 30% of
energy from protein, carbohydrates, and fats, respectively (Table 1).
Rats were trained to consume three meals/day consisting of 4-g meals
at 0700 and 1300 and a 6-g meal at 1800. These meals provided 80%
of daily ad libitum intake, which insured that energy intake was equal
and that all food was consumed rapidly (within 20 min of introduc-
tion; Fig. 1). This food restriction protocol does not alter development
of lean tissue but reduces accumulation of body fat (20).
Experimental treatments. After 7 days of meal training, rats were
food deprived for 12 h (1900–0700) and then euthanized premeal at
time 0 (food deprived) or at 90 or 180 min after the 4-g test meal.
Based on our previous study (28), the 90-min time point represented
peak MPS activity, whereas the 180-min time point reflected a period
of time when mTORC1 signaling and initiation factor activity was
elevated, but MPS returned to baseline values. At 135 min after the
test meal, rats were administered a 5-ml oral gavage of carbohydrates
(CHO), leucine (Leu), CHO  Leu (LC), or a sham (water) control
(Fig. 1).
The CHO supplement contained 2.63 g of CHO (1.315 g of glucose
1.315 g of sucrose) in distilled water, which was slightly greater than
the carbohydrate content of the 4 g meal (2.2 g). The Leu supple-
ment contained 270 mg of Leu in distilled water, which was equiva-
lent to the daily amount of Leu consumed by rats of this age and
strain, with free access to the AIN-93 powdered diet (Harlan-Teklad)
(19) and nearly three times the leucine content of the 4-g meal (100
mg). The LC supplement contained 2.36 g of CHO (1.18 g of glucose 
1.18 g of sucrose) and 270 mg of Leu in distilled water, which was
isocaloric with the CHO gavage and isonitrogenous with the Leu
gavage. The CHO and LC supplements supplied 15% of daily
energy intake for this age and strain of rat (19). The amounts and
timing of the supplements were based on our previous research that
produced maximal Leu- and insulin-induced stimulations of transla-
tion initiation and MPS 45 min after oral gavage (2, 3, 6, 12).
Administration of metabolic tracer and sample collection. MPS
was measured in skeletal muscle using the flooding dose method (18).
A 100% enriched L-[2H5]phenylalanine solution (150 mmol/l; Cam-
bridge Isotopes, Andover, MA) was administered at 150 mmol/100 g
body wt and injected via tail vein (1 ml/100 g body wt). After 10 min,
animals were euthanized by decapitation, blood was collected in
precoated EDTA tubes, and hindlimbs were quickly removed and
immersed in an ice-water mixture. Gastrocnemius muscles were
removed from cooled hindlimbs, frozen in liquid N2, and stored at
80°C.
Determination of MPS. Frozen muscle tissue was powdered in
liquid nitrogen, and protein was precipitated with cold (4°C) perchlo-
ric acid (30 g/l, 1 ml/50 mg muscle tissue). The resulting supernatant
and protein pellet were prepared for MPS analysis, as described
previously (16, 26). The enrichment of L-[2H5]phenylalanine in the
muscle hydrolysate was measured by GC-MS using a 6890N GC and
a 5973N mass detector (Agilent Technologies, Santa Clara, CA).
Samples were analyzed under electron impact ionization in splitless
mode, and the mass-to-charge ratio of phenylethylamine ions at 106
(m  2) and 109 (m  5) were monitored for enrichment.
The muscle supernatant was used to determine intracellular free
phenylalanine enrichment. Free amino acids were purified by ion
exchange resin solid-phase extraction using the EZ Fast amino acid
analysis sample testing kit (Phenomenex, Torrance, CA), and
L-[2H5]phenylalanine enrichment was determined using a propyl chlo-
roformate derivative with GC-MS by monitoring the ions at mass-to-
charge ratios of 206 (m) and 211 (m  5) (27).
MPS was assessed from the rate of incorporation of L-[2H5]phenylalanine
into total mixed-muscle protein, as described previously (26). The
time from injection of the tracer until tissue cooling was recorded as
the actual time for L-[2H5]phenylalanine incorporation. MPS, defined
as the percentage of tissue protein renewed each day, was calculated
according to the formula MPS  (Eb  100)/(Ea  t), where t is the
time interval between injection and cooling of sampled tissue ex-
pressed in days and Eb and Ea are the enrichments of [2H5]Phe in
hydrolyzed tissue protein and muscle free amino acids, respectively.
Table 1. Meal composition
Components g/kg
Whey protein isolate* 1228.0
Corn starch 290.0
Maltodextrin 134.1
Sucrose 101.5
Soybean oil 140.9
Cellulose 53.7
Mineral mix† 37.6
Vitamin mix† 10.7
Choline bitautrate 2.7
TBHQ 0.014
TBHQ, tertiary butylhydroquinone. *Whey protein provided by Bongard’s
Creameries, Perham, MN (89.9% protein, 3.8% carbohydrate, and 6.3% other).
†Purchased from Harlan-Teklad, Madison, WI.
Fig. 1. Experimental design and timeline. Treatment groups were intubated at
135 min after the meal with water (sham), carbohydrates (CHO), leucine (Leu),
or combination of CHO  Leu (LC).
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Plasma measurements. Plasma was obtained from trunk blood by
centrifugation at 1,800 g for 10 min at 4°C. Plasma insulin concen-
trations were analyzed using a commercial RIA kit for rat insulin
(Millipore, Billerica, MA). Plasma amino acid concentrations were
determined by HPLC using a Waters (Milford, MA) 2475 fluores-
cence detector (30).
Western blot analysis. Muscle supernatants were subjected to protein
immunoblot analysis, as described previously (12). Rabbit polyclonal
antibodies were used for total and phosphorylated (phospho)-S6K1
(Thr389), total and phospho-4E-BP1 (Thr37/46), total and phospho-eukary-
otic elongation factor 2 (eEF2; Thr56), total and phospho-AMPK
(Thr172), total and phospho-ACC (acetyl-CoA carboxylase; Ser79),
total and phospho-Akt (Ser473), and total and phospho-eIF2 (Ser51;
eIF2) as well as total and phospho-eIF2Bε (phospho-Ser535) (Invitro-
gen, Camarillo, CA). All primary antibodies used were purchased from
Cell Signaling Technology (Boston, MA) unless stated otherwise. Anti-
rabbit IgG, horseradish peroxidase-linked secondary antibody was also
purchased from Cell Signaling Technology.
Nucleotide analysis. Adenosine 5=-monophosphate (AMP) and
adenosine 5=-triphosphate (ATP) were determined by HPLC analysis,
as described in a technical note CN-039 by Phenomenex (Torrance,
CA). Briefly, frozen gastrocnemius muscle was ground under liquid
nitrogen, and 50 mg of sample was combined with 1 ml of MeOH in
water (25:75) and vortexed. This sample was centrifuged at 10,000
rpm at 4°C for 5 min, and the supernatant was extracted. The
supernatant was dried and then reconstituted in phosphate-buffered
saline. The sample was then passed through a Strata X-AW 33u
Polymeric Weak Anion Solid Phase Extraction Sorbent (Phenomenex,
Torrance, CA). Ten-microliter aliquots of the final muscle extract
were injected onto the HPLC using a Phenomenex Gemini 5u C18
110A Column 150  4.6 mm with temperature set at 25°C. A single
mobile phase was used at a flow rate of 1 ml/min with 25% acetoni-
trile-10 mM KH2PO4, pH 7.0 (pH was adjusted with potassium
hydroxide/5 mM tetrabutylammonium chloride). Nucleotide peaks
were measured by UV detection at a wavelength of 260 nm. Peaks
were identified by comparison with external standards (Sigma-Al-
drich, St. Louis, MO).
Statistical analysis. All data were analyzed by SPSS 15.0 software
package for Windows (Chicago, IL). A one-way ANOVA was per-
formed with the postprandial times and oral gavage treatments as the
independent variables. When a significant overall effect was detected,
differences among individual means were assessed using a least
significant difference post hoc test. For plasma amino acids, a one-
way ANOVA was performed for meal (0, 90, and 180 min) and
supplement effects (sham, CHO, Leu, and LC at 180 min). Correla-
tions were determined by linear regression (Pearson correlation). The
level of significance was set at P 0.05 for all statistical tests. Values
are presented as means  SE.
RESULTS
This experiment evaluated the potential for supplemental
Leu or CHO to extend the peak MPS response after a meal.
Consistent with our previous research (28), we found that MPS
increased at 90 min after a 4-g test meal but then returned to
food-deprived values at 180 min (sham). Supplementation with
Leu, CHO, or LC 135 min after the test meal significantly
increased MPS at 180 min above sham rats and equal to
meal-fed rats at 90 min (Fig. 2).
To understand the mechanisms explaining these findings, we
first examined changes in plasma amino acid concentrations.
As expected, plasma leucine and EAAs increased 90 min after
the meal and remained elevated at 180 min (Table 2).
Administering the Leu supplements at 135 min elevated
plasma leucine at 180 min; however, Leu and LC also de-
pressed plasma isoleucine and valine below sham values
(Fig. 3). Likewise, the CHO gavage lowered plasma branched-
chain amino acids (BCAA; Leu, isoleucine, and valine) below
sham levels. The supplements had no effect on levels of other
measured plasma EAAs, including methionine, threonine, and
lysine, relative to Sham control (Fig. 3).
Phosphorylation of S6K1 (Thr389) was measured as a marker
of mTORC1 signaling. Consistent with previous reports (8,
28), relative phosphorylation of S6K1 (Thr389) in muscle
increased at 90 min (P 0.05) and remain elevated at 180 min
Fig. 2. Postprandial changes for muscle protein synthesis (MPS). Treatment
groups were intubated at 135 min after the meal with water (sham), CHO, Leu,
or LC. Data are means  SE; n  4–6. Means without a common letter differ
(P  0.05).
Table 2. Postprandial concentrations of selected essential
amino acids in plasma following meal consumption
Time, min 0* 90 180
Leucine 200 18b 297  31a 312  19a
Isoleucine 100 11b 150  16a 148  12a
Valine 171 19a 221  25a 243  13a
Lysine 569 33b 724  61a 595  38a,b
Methionine 72 8a 88  6a 88  5a
Threonine 799 96a 982  71a 993  68a
Values are expressed as means  SE and in 	mol/l; n  4–6. Means
without a common letter differ (P  0.05). *Twelve-hour food-deprived
controls.
Fig. 3. %Difference of selected plasma amino acid concentrations from control
(sham treatment) for each supplement. Data are means SE; n 6. Treatment
groups were intubated at 135 min after the meal with water (sham), CHO, Leu,
or LC, with measurements taken 180 min after the meal. Means without a
common letter differ (P  0.05). *Amino acid differs from sham (P  0.05).
Ile, isoleucine; Val, valine; Lys, lysine; Met, methionine; Thr, threonine.
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(sham control) compared with food-deprived rats (time 0, P 
0.05; Fig. 4). Likewise, supplemental treatments maintained
S6K1 activation at 180 min. From 0 to 90 min, there was a
significant correlation between S6K1 phosphorylation and
MPS (r  0.843, P  0.05). However, from 90 to 180 min
after the meal, no statistical correlation was present (r 0.163,
P 
 0.05). Similar results were seen for phospho-4E-BP1
(Thr37/46; Fig. 4).
To evaluate other steps in translation initiation, we examined
phosphorylation of regulatory sites in eIF2 (Ser51) and
eIF2Bε (Ser535) as markers of eIF2 activation. No changes in
phosphorylation of either of these proteins were found (data
not shown).
Consistent with earlier publications (8, 28), plasma insulin
rose at 90 min postmeal and returned to food-deprived (time 0)
values at 180 min (sham) (Fig. 5). The CHO and LC supple-
ments maintained elevated insulin at 180 min, whereas the Leu
supplement was not different from the sham group at 180 min.
Phosphorylation of Akt (Ser473) was measured as an indicator
of insulin signaling, but no differences in Akt activation were
detected among the groups at 180 min (data not shown).
Since the decline in MPS at 180 min postmeal (sham) was
not related to changes in EAAs, plasma insulin, or phosphor-
ylation of S6K1, eIF2, or eIF2Bε, we then examined phos-
phorylation of eEF2 (Thr56), an essential regulator of transla-
tion elongation. After the meal, eEF2 phosphorylation de-
creased from 0 to 90 min, reflecting activation of elongation for
MPS, but returned to food-deprived (time 0) values at 180 min
postmeal (sham control), consistent with inhibition of elonga-
tion (Fig. 6) and the decline in MPS. All three supplements
(Leu, CHO, and LC) reduced eEF2 phosphorylation at 180 min
relative to sham control. Across all treatment groups, there was
an inverse association between phospho-eEF2 and MPS (r 
0.500, P  0.05).
Phosphorylation of AMPK (Thr172) and its substrate ACC
(Ser79) and the nucleotide ratio of AMP/ATP were measured as
indicators of cellular energy status (Fig. 7). In meal-fed rats,
phosphorylation of muscle AMPK and ACC (21) declined at
90 min compared with food-deprived rats, reflecting increased
energy availability, but increased at 180 min, reflecting de-
creased energy availability. All three of the supplemental
treatments maintained reduced phospho-AMPK and ACC at
levels similar to the 90-min postmeal values. Similarly to
changes in phospho-AMPK and ACC, the ratio of AMP/ATP
[allosteric regulator of AMPK (22) and a direct measurement
of cellular energy status] declined at 90-min postmeal but
increased above food-deprived values at 180 min. Each of the
supplements served to maintain a reduced ratio of AMP/ATP at
180 min, consistent with the behaviors of AMPK and ACC.
DISCUSSION
This study demonstrates that Leu or CHO supplements
provided 2 h after consumption of a complete meal can
extend the postprandial anabolic period of MPS (Fig. 2).
Furthermore, the findings of this study suggest that the incon-
gruity between MPS and mTORC1 signaling 180 min after a
meal is associated with activation of AMPK (Fig. 7) and
reduced translation elongation activity (Fig. 6). These data
suggest that temporal changes in skeletal muscle energy state
Fig. 4. Postprandial changes in the relative phosphorylation state of ribosomal
S6 protein kinase 1 [phospho-S6K1 (Thr389)/total S6K1] and eukaryotic
initiation factor-4E (eIF4E)-binding protein-1 [phospho-4E-BP1 (Thr37/46)/
total 4E-BP1]. Treatment groups were intubated at 135 min after the meal with
water (sham), CHO, Leu, or LC. Data are means  SE; n  4–6. Means
without a common letter differ (P  0.05).
Fig. 5. Postprandial changes in plasma insulin. Treatment groups were intu-
bated at 135 min after the meal with water (sham), CHO, Leu, LC. Data are
means  SE; n  4–6. Means without a common letter differ (P  0.05).
Fig. 6. Postprandial changes in the relative phosphorylation state of eukaryotic
elongation factor 2 [phospho-eEF2 (Thr56)/total eEF2]. Treatment groups were
intubated at 135 min after the meal with water (sham), CHO, Leu, or LC. Data
are means  SE; n  4–6. Means without a common letter differ (P  0.05).
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following meal feeding influence the period of muscle anabo-
lism. Furthermore, the energy status of muscle can be enhanced
by postmeal nutrition supplements to extend the period of
muscle anabolism.
Translation initiation is a critical regulatory step for stimu-
lating the rise in MPS after a meal and is activated by nutrient
signals derived from changes in plasma insulin and Leu and
propagated through the PI3K-Akt-mTORC1 signaling cascade
(4). Triggering of initiation and maximum MPS activity occurs
within 30 to 60 min following administration of free Leu (6)
and 60 to 90 min following ingestion of intact proteins (8, 28).
Two recent studies (8, 28) using precisely timed meals con-
taining intact proteins confirmed that the early postprandial rise
of MPS (2 h) corresponded to increases in plasma insulin and
Leu, as well as phosphorylation of S6K1 and 4E-BP1 and
assembly of the eIF4F initiation complex, but found that MPS
declined after 3 h despite continued elevations of plasma Leu,
mTORC1 signaling, and translation initiation. The present
study is consistent with these reports, finding a postprandial
rise in plasma Leu and significant correlation between
phospho-S6K1 and MPS (r  0.843, P  0.05) from 0 to 90
min after the test meal (Fig. 4). However, from 90 to 180 min
postmeal, the correlation between phospho-S6K1 and MPS
disappears (r  0.163, P 
 0.05; Fig. 4). Likewise, similar
results were found for phospho-4E-BP1 (Fig. 4). Furthermore,
no changes in the phosphorylation states of eIF2 or eIF2Bε
were found, suggesting that eIF2 is unlikely to be a regulatory
factor for postprandial changes in MPS. Collectively, these
findings are consistent with the hypothesis that translation
initiation signaling via mTORC1 facilitates the initial rise in
MPS after a meal; however, factors in addition to translation
initiation are required to sustain peak MPS 180 min after a
meal (8, 28).
Potential explanations for the discordance between initiation
signals and the postprandial duration of MPS include 1) factors
or steps within mRNA translation becoming refractory (unre-
sponsive) to external stimuli, 2) reduced availability of amino
acids, or 3) reduced signaling from insulin or other important
signals. In the present study, all three nutrient supplements
were able to extend the duration of peak MPS, demonstrating
that mRNA translation is not refractory to anabolic stimuli but
rather limited by one or more regulatory factors. Therefore, we
sought to determine what factors limited the postprandial
duration of MPS and why either Leu or CHO supplements
overcame these limitation(s).
We found that plasma essential amino acids remained ele-
vated at 180 min after the meal (sham control) relative to the
90-min time point and that Leu or CHO treatments were
sufficient to extend MPS without providing additional amino
acids (Table 2), establishing that availability of essential amino
acids was not a primary limitation during the decline in MPS.
Likewise, insulin does not appear to be a critical factor in
extending MPS (Fig. 5). As expected, the CHO treatments
(CHO and LC) increased plasma insulin concentration at 180
min compared with the sham control; however, the Leu treat-
ment, which prolonged the duration of MPS at 180 min, did not
maintain elevated insulin concentration at 180 min. There were
no differences between groups in phosphorylation of the insu-
lin-signaling target Akt at 180 min (data not shown). However,
we have shown previously that peak insulin and Akt responses
occur 30 min after a complete meal (14) and 20 min after
administration of these supplements (4). Therefore, the time
point measurements used in this study most likely missed peak
insulin and Akt responses. Thus, the influence of insulin
signaling on the duration of MPS remains unresolved.
Another possible determinant of the postmeal reduction in
MPS is a decrease in translation elongation. In this experiment,
phosphorylation of eEF2 (Thr56) was used as an indicator for
translation elongation activity. We found increased phosphor-
ylation of eEF2 in the sham control, indicating inhibition of
eEF2 at 180 min after the test meal (Fig. 6). Conversely,
phosphorylation of eEF2 was reduced by each of the supple-
ments at 180 min, consistent with sustained elevation of MPS
after the meal.
Brown et al. (11) and Horman et al. (23) have shown that
inhibition of eEF2 and protein synthesis in response to mild
energy deficits is associated with activation of AMPK, which
stimulates the regulatory kinase eEF2 kinase to subsequently
phosphorylate (inhibit) eEF2. The ability of AMPK to respond
to changes in AMP/ATP, with AMP stimulating AMPK and
ATP inhibiting it, allows this kinase to be an effective cellular
energy sensor (22). We measured AMPK phosphorylation,
the ratio of AMP/ATP, and phosphorylation of ACC to deter-
mine whether energy status of muscle could be a limiting factor
for MPS 180 min after a meal (Fig. 7). Consistent with the
energy hypothesis, each of the biomarkers for cellular energy
status reflected energy stress in the cell and produced a pattern
of change nearly identical with that observed for eEF2 (Fig. 6).
Furthermore, there was a significant inverse correlation across
treatments between MPS and AMPK phosphorylation (r 
0.581, P  0.05). Collectively, these results suggest that
energy is a likely determinant of the duration of postprandial
MPS and that eEF2 is the regulatory step responding to energy
status.
When considering the upstream regulators of translation
initiation and elongation, there appears to be a paradox in these
signals. Indeed, AMPK and mTORC1 are both regulators of
translation initiation and elongation but act in opposing ways,
Fig. 7. Postprandial changes in the relative phosphorylation states of adenosine
monophosphate-activated protein kinase- [phospho-AMPK (Thr172)/total
AMPK] and acetyl-CoA carboxylase [phospho-ACC (Ser79)/total ACC] and
nucleotide ratio of AMP/ATP (adenosine 5=-monophosphate/adenosine 5=-
triphosphate). Treatment groups were intubated at 135 min after the meal with
water (sham), CHO, Leu, or LC. Data are expressed as %change from fasted
(time 0) values. Data are means  SE; n  4–6. Means without a common
letter differ (P  0.05).
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with AMPK inhibiting translation initiation (7) and elongation
(10) and mTORC1 stimulating these processes (33). The find-
ings that both mTORC1 (8, 28) and AMPK (Fig. 7) are
activated during the postprandial decline in MPS suggests that
AMPK and energy become the dominant signals. Furthermore,
the finding that eEF2, a key regulator of translation elongation,
is inhibited, coinciding with downregulation of MPS, indicates
that the AMPK inhibitory effect on eEF2 overrides the stimu-
latory effects of mTORC1.
Support for this hierarchal form of regulation is provided
from research by Browne and colleagues (10, 11), Horman et
al. (23), McLeod and Proud (25), and Smith et al. (32). In a
variety of cell lines (10, 23, 25, 32) these authors have shown
that, under mild energy deficits, AMPK activation results in
strong and rapid inhibition of eEF2 and translation elongation,
with no corresponding changes in phosphorylation of proteins
involved in the initiation stages of mRNA translation, includ-
ing eIF2, p70 S6K1, 4E-BP1, and assembly of the eIF4F
initiation complex. Contrary to these findings, Dennis et al.
(13) demonstrated inhibition of mTORC1 signaling using
higher concentrations of the AMPK agonist 2-deoxyglucose
[10-fold greater than Browne and colleagues (10, 11), Horman
et al. (23), McLeod and Proud (25), and Smith et al. (32)].
Likewise, Williamson et al. (35) reported inhibition of
mTORC1 signaling by AMPK using higher levels of 5-ami-
noimidazole-4-carboxamide-1--D-ribonucleoside [double the
amount of Browne and colleagues (10, 11), Horman et al. (23),
McLeod and Proud (25), and Smith et al. (32)]. Overall, the
current study and the published reports by Browne and col-
leagues (10, 11), Horman et al. (23), McLeod and Proud (25),
and Smith et al. (32) suggest that the physiological regulation
of cellular energy status by AMPK exerts a dominant effect
over the anabolic stimulation of MPS by mTORC1.
Considering that protein turnover is a metabolically costly
process, accounting for approximately one-quarter of resting
energy expenditure (34), it is logical that a cell would suppress
protein synthesis activity during an energy deficit to preserve
critical functions. Furthermore, when considering that transla-
tion elongation accounts for the majority (
99%) of the energy
used for polypeptide assembly (10, 11, 29), it appears logical
that the cell would regulate translation elongation to protect
energy status.
The finding that the large Leu supplement was able to
decrease AMPK phosphorylation is consistent with the work
from Du et al. (15), who showed that Leu treatment in C2C12
myoblast cells resulted in a 36% decrease in the AMP/ATP
ratio, a 28% reduction in phospho-AMPK, and a 43% reduc-
tion in AMPK activity. Leu can provide energy (ATP) to
muscle by conversion to ketoisocaproate (KIC) and its subse-
quent oxidation via the TCA cycle. Increased KIC levels in
skeletal muscle have also been shown to increase oxidation of
all three BCAAs (Leu, isoleucine, and valine) by allosteric
activation of branched-chain -keto-acid dehydrogenase (1,
17). In support of the hypothesis that Leu increased BCAA
oxidation, the Leu-containing supplements in the present ex-
periment reduced isoleucine and valine concentrations by 50–
150%, whereas other plasma EAAs remained unchanged rela-
tive to sham control (Fig. 3).
In summary, intake of a Leu or CHO supplements2 h after
consumption of a complete meal can extend the duration of the
postprandial rise in MPS. Furthermore, the incongruity be-
tween MPS and mTORC1 signaling at 180 min after the meal
does not reflect a refractory period or decreased sensitivity to
anabolic stimuli but rather an increase in AMPK activity and a
decrease in translation elongation activity. Improved under-
standing of factors that regulate the duration of MPS may have
implications for maintenance of lean tissue during weight loss
or aging for treatment of patients suffering trauma or prolonged
bed rest as well as for acceleration of muscle development in
athletes. As such, the roles of eEF2 and AMPK in regulation of
postprandial MPS warrant further investigation.
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